Patents by Inventor Jussi Halleen

Jussi Halleen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180008627
    Abstract: The present invention relates to preventing and/or treating urologic diseases and symptoms in humans or domestic animals. The present invention relates also to preventing and/or treating pain in the pelvic area. The invention relates to use of a heteropolysaccharide composition isolated from ligneous plants and comprising hemicelluloses, mainly glucomannans, but also xylans and pectic polysaccharides, as well as fractions, subgroups or mixtures of these, as pharmaceutical preparations, food additives and food products.
    Type: Application
    Filed: September 7, 2017
    Publication date: January 11, 2018
    Inventors: Yvonne KONKOL, Jenni BERNOULLI, Bjarne HOLMBOM, Heikki VUORIKOSKI, Andrey PRANOVICH, Jussi HALLEEN
  • Publication number: 20150306133
    Abstract: The present invention relates to preventing and/or treating urologic diseases and symptoms in humans or domestic animals. The present invention relates also to preventing and/or treating pain in the pelvic area. The invention relates to use of a heteropolysaccharide composition isolated from ligneous plants and comprising hemicelluloses, mainly glucomannans, but also xylans and pectic polysaccharides, as well as fractions, subgroups or mixtures of these, as pharmaceutical preparations, food additives and food products.
    Type: Application
    Filed: November 8, 2013
    Publication date: October 29, 2015
    Inventors: Yvonne Konkol, Jenni Bernoulli, Bjarne Holmbom, Heikki Vuorikoski, Andrey Pranovich, Jussi Halleen
  • Publication number: 20110105349
    Abstract: The present invention relates to the use of a monophosphate ester of a phthalein compound as a substrate for Tartrate-Resistant Acid Phosphotase (TRAP). The substrate is used in assays for obtaining a measure of the amount of TRAP 5b in a sample of a subject, as an indication of the rate of bone resorption and therefore the likelihood of conditions such as osteoporosis. Also provided are kits comprising a monophosphate ester of a phthalein compound and optionally an antibody which binds total TRAP and methods.
    Type: Application
    Filed: April 8, 2009
    Publication date: May 5, 2011
    Applicant: MUNODIAGNOSTIC SYSTEMS LIMITED
    Inventors: Brian Houston, David Laurie, Jussi Halleen
  • Patent number: 6248544
    Abstract: Tartrate-resistant acid phosphatase (TRAP) has been used as a marker for bone resorption. However, there are two forms of said enzyme in the body: TRAP 5a and TRAP 5b, of which TRAP 5b is a much more specific marker. The present invention is directed to an immunoassay for measuring the bone resorption rate, which methods enables the specific determination of TRAP 5b, whereby the amount of TRAP 5b reflects the bone resorption rate. The method is useful in diagnosing disorders associated with a change in the bone resorption rate, such as osteoporosis. Methods of screening for susceptibility to such disorders, and method of monitoring the effect of treatment are also provided. Further a test-kit useful in said methods is provided.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: June 19, 2001
    Inventors: Jussi Halleen, Kalervo V{umlaut over (aa)}nänen